Gene Therapies for Spinal Cord-Related Disorders with SwanBio's CEO
- Author
- Erin Harris
- Published
- Thu 16 Sep 2021
- Episode Link
- None
We love to hear from our listeners. Send us a message.
Karen Kozarsky, Ph.D., Co-Founder and CSO of SwanBio, explains how the company is pioneering a deep and varied pipeline of gene therapies for genetically defined neurological diseases with a focus on the spinal cord.
Subscribe to the podcast!
Apple | Spotify | YouTube
Visit my website: Cell & Gene
Connect with me on LinkedIn
